OWKIN en las noticias
Plataforma de descubrimiento biológico con IA
Tamtam encontró 20 artículos recientes sobre OWKIN.
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Owkin: Pioneering Biological Artificial Superintelligence for the Future of Medicine
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Q&A: Owkin’s five-year Sanofi deal bets on ‘purpose-built’ AI agents
- Sanofi expands AI ambitions through new Owkin collaboration
- Owkin and Sanofi Expand Partnership to Develop AI Agents Through K Pro Collaboration
- Sanofi and Owkin partner to develop next-generation biopharma AI agents
- Sanofi Owkin AI Deal Puts R&D Shift And Valuation In Focus
- Owkin To Build AI Agents As Part Of A Multi-Year K Pro Collaboration With Sanofi
- Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative - Sanofi (NASDAQ:SNY)
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Sanofi deepens its Owkin bet with a five-year deal to build bespoke drug-development agents
- Owkin, Sanofi expand AI collaboration to build drug development AI agents
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative
- Why AI models need patient data to deliver in drug discovery
- OWKIN Showcases AI-Driven Trial De-Risking Capabilities at Harvard Symposium
- OWKIN Highlights AI Metric Choice to Improve Oncology Target Discovery
- OWKIN Deepens U.K. Data Network and Sharpens AI Biology Strategy Amid Sector Funding Shifts
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como OWKIN?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares